Biostax Corp.
BTAX
$0.01
$0.00111.11%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 13.45% | -5.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.08% | -9.55% | |||
| Operating Income | -13.08% | 9.55% | |||
| Income Before Tax | -26.97% | 68.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -26.97% | 68.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.97% | 68.00% | |||
| EBIT | -13.08% | 9.55% | |||
| EBITDA | -13.78% | 9.94% | |||
| EPS Basic | -27.50% | 68.25% | |||
| Normalized Basic EPS | -28.00% | 10.71% | |||
| EPS Diluted | -150.00% | 68.25% | |||
| Normalized Diluted EPS | -28.00% | 10.71% | |||
| Average Basic Shares Outstanding | -0.02% | 0.07% | |||
| Average Diluted Shares Outstanding | -2.43% | 2.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
